HomeCompareADDLF vs PLD

ADDLF vs PLD: Dividend Comparison 2026

ADDLF yields 0.19% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.48M in total portfolio value
10 years
ADDLF
ADDLF
● Live price
0.19%
Share price
$42.00
Annual div
$0.08
5Y div CAGR
49%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$1,143.40
Full ADDLF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — ADDLF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADDLFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADDLF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADDLF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADDLF
Annual income on $10K today (after 15% tax)
$15.94/yr
After 10yr DRIP, annual income (after tax)
$971.89/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,466,998.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADDLF + PLD for your $10,000?

ADDLF: 50%PLD: 50%
100% PLD50/50100% ADDLF
Portfolio after 10yr
$3.26M
Annual income
$2,628,789.79/yr
Blended yield
80.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ADDLF
No analyst data
Altman Z
5.0
Piotroski
8/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADDLF buys
0
PLD buys
0
No recent congressional trades found for ADDLF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADDLFPLD
Forward yield0.19%3.18%
Annual dividend / share$0.08$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR49%74.4%
Portfolio after 10y$23.4K$6.50M
Annual income after 10y$1,143.40$5,256,436.18
Total dividends collected$3.3K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ADDLF vs PLD ($10,000, DRIP)

YearADDLF PortfolioADDLF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,728$27.93$11,255$555.24$527.00PLD
2$11,521$41.73$13,062$1,018.59$1.5KPLD
3$12,389$62.40$15,903$1,926.67$3.5KPLD
4$13,350$93.45$20,839$3,823.32$7.5KPLD
5$14,425$140.23$30,464$8,166.08$16.0KPLD
6$15,646$210.99$52,054$19,457.30$36.4KPLD
7$17,060$318.67$109,886$54,188.93$92.8KPLD
8$18,738$483.86$304,030$186,451.18$285.3KPLD
9$20,789$740.07$1,166,125$840,813.32$1.15MPLD
10$23,388$1,143.40$6,504,190$5,256,436.18$6.48MPLD

ADDLF vs PLD: Complete Analysis 2026

ADDLFStock

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Full ADDLF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ADDLF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADDLF vs SCHDADDLF vs JEPIADDLF vs OADDLF vs KOADDLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.